Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-120279
Filing Date
2024-11-04
Accepted
2024-11-04 07:15:22
Documents
73
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q dtil-20240930.htm   iXBRL 10-Q 2663358
2 EX-10.1 dtil-ex10_1.htm EX-10.1 68667
3 EX-10.5 dtil-ex10_5.htm EX-10.5 29395
4 EX-10.7 dtil-ex10_7.htm EX-10.7 270172
5 EX-31.1 dtil-ex31_1.htm EX-31.1 17749
6 EX-31.2 dtil-ex31_2.htm EX-31.2 17631
7 EX-32.1 dtil-ex32_1.htm EX-32.1 10168
8 EX-32.2 dtil-ex32_2.htm EX-32.2 10148
  Complete submission text file 0000950170-24-120279.txt   9948395

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT dtil-20240930.xsd EX-101.SCH 1359951
76 EXTRACTED XBRL INSTANCE DOCUMENT dtil-20240930_htm.xml XML 1504345
Mailing Address 302 EAST PETTIGREW STREET SUITE A-100 DURHAM NC 27701
Business Address 302 EAST PETTIGREW STREET SUITE A-100 DURHAM NC 27701 919-314-5512
PRECISION BIOSCIENCES INC (Filer) CIK: 0001357874 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38841 | Film No.: 241420743
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)